DREADD agonist 21 dihydrochloride , 0.98 , 2250025-92-2
CAS NO.：2250025-92-2
Empirical Formula: C17H19ClN4
Molecular Weight: 314.82
MDL number: MFCD31689249
PRODUCT Properties
| solubility | Soluble to 100 mM in water and to 100 mM in DMSO |
| form | solid |
| color | Yellow |
| Appearance | yellow-brown powder |
| Water Solubility | Soluble in water (100mM). Always store solutions at -20°C. |
Description and Uses
DREADD agonist 21 (Compound 21, C21) is a synthetic compound for selective activation of hM3Dq (excitatory) and hM4Di (inhibitory) DREADDs (Designer Receptor Exclusively Activated by Designer Drugs) derived from the human muscarinic acetylcholine M3 (hM3) receptor. It does not agonize the hM3 receptor and displays weaker binding affinities for histamine H1, serotonin 5-HT2A, 5-HT2C, and α1A-adrenergic receptors (Ki = 6, 66, 170, and 280 nM, respectively) [1].
DREADD agonist 21 is routinely used as a chemogenetic tool for remotely controlling neuronal activity. It displays excellent brain permeability and capability to activate neurons expressing hM3Dq DREADDs and inhibit activity in neurons expressing hM4Di DREADDs in vivo [2].
This product is dihydrochloride salt, a water-soluble version of DREADD agonist 21.
[1] Chen X. et al. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs. ACS Chem. Neurosci. 2015. 6(3). 476-484.
[2] Thompson K.J. et al. DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo. ACS Pharmacol. Transl. Sci. 2018. 1(1). 61-72.
DREADD agonist 21 dihydrochloride is a potent human muscarinic acetylcholine M3 receptors (hM3Dq) agonist (EC50=1.7 nM)[1].